The Role of Interferon Beta Administration in COVID-19 Treatment |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.14, No. 4)Publication Date: 2021-10-14
Authors : Salam Sardiah; Lewa' Alzaleq;
Page : 310-311
Keywords : Interferon β; COVID-19; Coronavirus; SARS-CoV-2; Patients;
Abstract
Coronavirus disease 2019 (COVID-19) is still a major challenging pandemic in our century and has become a public health concern. Although many safe COVID-19 vaccines are introduced to the public, new variants of the virus still exist, which make the infection more severe and associated with faster spread. Until now, there is a lack of effective therapeutic options for treatment, so many efforts have been raised to find promising effective agents. Interferons (IFNs) are a group of cytokines produced in response to infections with antiviral and immune-modulating actions. Previous studies revealed IFNs efficacy in Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). It's recommended that early administration of IFN-β (within 7 days from the onset of symptoms) might improve survival rate and clinical response and decrease mortality among COVID-19 patients.
Other Latest Articles
- INTERVENING ROLE OF WORK SATISFACTION AND COMPANY COMMITMENT IN THE CONNECTION BETWEEN HRM PROCESSES AND INTENT OF EMPLOYEES TO QUIT
- Assessment of Stress and Stress Management Among Sho’s With Reference To My Suru: An Empirical Study
- An Analysis of Rural Indian Banks' Performance with Emphasis on Karnataka Vikas Grameena Bank
- EVALUATION OF MULTICOMPONENT BIOCIDE FOR PROTECTION OF PLYWOOD
- COMPREHENSIVE EVALUATION OF PREGNANCY COMPLICATIONS AT A TERTIARY CARE TEACHING HOSPITAL
Last modified: 2023-11-03 22:08:37